Fibroblast Proliferation Assay
Fibroblast Proliferation Assay - Related Videos
02:46
An In Vitro Assay for Evaluating the Immunomodulatory Impact of Monocytes on Leukocyte Proliferation
0 Views •
2025
This video demonstrates an in vitro assay to explore the immunomodulatory influence of mesenchymal stem cells (MSCs) on effector T cell proliferation. The assay includes co-culturing MSCs with PBMCs to induce the monocyte population to acquire an immunomodulatory phenotype, leading to the secretion of interleukin-10 (IL-10). Following incubation with activated CD4+ T cells, the induced monocytes effectively suppress T cell proliferation.
03:48
Choroid Sprouting Assay to Study Ocular Microvascular Proliferation Ex Vivo
0 Views •
2025
This video demonstrates the development of an ex vivo model of choroidal sprouting to study ocular microvascular angiogenesis. The assay involves culturing mouse eye explants containing the choroid tissue attached to the sclera and retinal pigment epithelium under specific conditions that promote choroidal microvascular sprouting.
03:59
Bromodeoxyuridine Pulse Labelling Assay: A Technique to Measure Cell Proliferation
0 Views •
2023
The video describes the stepwise pulse labeling assay of mammalian cells with bromodeoxyuridine (BrdU) for measuring cell proliferation. The BrdU uptake permits the temporal tracking of cells that were in the synthesis phase at a specific point in time, without requiring the cells to be synchronized.
10:51
Preparation and Metabolic Assay of 3-dimensional Spheroid Co-cultures of Pancreatic Cancer Cells and Fibroblasts
0 Views •
Cited by 31 •
2017
Here, a method is described for the preparation of 3-dimensional (3D) spheroid co-culture of pancreatic cancer cells and fibroblasts, followed by measurement of metabolic functions using an extracellular flux analyzer.
07:03
Determining Genome-wide Transcript Decay Rates in Proliferating and Quiescent Human Fibroblasts
0 Views •
Cited by 4 •
2018
We describe a protocol for generating proliferating and quiescent primary human dermal fibroblasts, monitoring transcript decay rates, and identifying differentially decaying genes.
FAQs
The assay can quantify proliferation through direct cell counts or through signals correlated with cell increase. DNA content, metabolic activity, and incorporation of a proliferation marker provide alternative measurements when counting cells is not the chosen approach. Because these readouts measure different indicators of growth, researchers select the signal that best matches the experimental comparison and study design.
Biomaterial composition, scaffold properties, surface treatments, growth factors, and drug candidates can all influence the observed response. These variables may promote or restrict fibroblast expansion under the defined culture conditions. Testing them with the same proliferation readout helps researchers evaluate cell compatibility and determine which material or treatment is most suitable for an engineered tissue strategy.
Direct counting measures the number of cells, whereas DNA content, metabolic activity, or marker incorporation provides an indirect signal associated with proliferation. The two approaches therefore describe growth through different measurable features. Selecting between them depends on how the experiment is organized and whether the study requires a cell-number measurement or a correlated laboratory signal.
Defined culture conditions provide a consistent setting for comparing fibroblast responses across biomaterials, scaffolds, surface treatments, growth factors, or drug candidates. When the surrounding conditions remain specified, differences in the proliferation readout can be related more clearly to the variable being evaluated. This consistency supports meaningful assessments of compatibility and cell expansion in bioengineering research.
A typical workflow cultures fibroblasts under defined conditions, exposes or maintains them in the experimental setting, and measures growth over time. The endpoint can be obtained by counting cells or by measuring DNA content, metabolic activity, or incorporation of a proliferation marker. Researchers then use the resulting comparison to assess how the tested material or treatment affects expansion.
Researchers use the assay when they need to determine how a biomaterial, scaffold property, or surface treatment influences fibroblast compatibility and expansion. The measured response can support comparisons among candidate designs before applying them to engineered tissue or wound-healing strategies. Growth factors and drug candidates can be assessed in the same general framework as additional experimental variables.
Results indicate how tested materials or treatments affect fibroblast growth, which is relevant to tissue repair and engineered tissue design. A proliferation response can therefore help researchers compare candidate biomaterials, scaffold features, surface modifications, growth factors, or drugs. These findings contribute to decisions about compatibility and cell expansion when developing bioengineering or wound-healing strategies.